D.E. Shaw & Co’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $971K | Sell |
151,502
-118,504
| -44% | -$760K | ﹤0.01% | 2234 |
|
|
2025
Q1 | $956K | Sell |
270,006
-36,738
| -12% | -$130K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $1.16M | Sell |
306,744
-384,322
| -56% | -$1.45M | ﹤0.01% | 2071 |
|
|
2024
Q3 | $2.24M | Sell |
691,066
-617,115
| -47% | -$2M | ﹤0.01% | 1743 |
|
|
2024
Q2 | $2.49M | Buy |
1,308,181
+265,598
| +25% | +$505K | ﹤0.01% | 1662 |
|
|
2024
Q1 | $2.96M | Buy |
1,042,583
+495,618
| +91% | +$1.41M | ﹤0.01% | 1555 |
|
|
2023
Q4 | $8.05M | Sell |
546,965
-213,325
| -28% | -$3.14M | 0.01% | 973 |
|
|
2023
Q3 | $13.9M | Sell |
760,290
-829,754
| -52% | -$15.2M | 0.01% | 668 |
|
|
2023
Q2 | $34.3M | Sell |
1,590,044
-432,326
| -21% | -$9.33M | 0.04% | 368 |
|
|
2023
Q1 | $59.3M | Buy |
2,022,370
+638,638
| +46% | +$18.7M | 0.06% | 236 |
|
|
2022
Q4 | $51.1M | Buy |
1,383,732
+1,221,467
| +753% | +$45.1M | 0.06% | 264 |
|
|
2022
Q3 | $4.57M | Buy |
+162,265
| New | +$4.57M | 0.01% | 1536 |
|